Medicus Pharma Ltd. Common Stock (MDCX)
MDCX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.28
-8.38% on the day
Market cap
$5.9M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | MDCX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001997296 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | A6 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B3 | 424B3 | 2026-10-07 |
| Latest annual report FORM 10-K/A | 10-K/A | 2026-04-29 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-12 |
| Latest current report FORM 8-K | 8-K | 2026-10-07 |
| Latest proxy FORM DEF 14A | DEF 14A | 2026-05-04 |
Source: SEC EDGAR submissions feed, 334 recent filings. All filings on EDGAR.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| MDCXW | Medicus Pharma Ltd. Warrant | $0.2990 |
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LEXX | Lexaria Bioscience Corp. | $2.80 | -14.37% | $5.9M |
| CANF | Can-Fite Biopharma Ltd | $1.95 | 0.00% | $5.9M |
| IMNN | Imunon Inc. | $1.07 | 0.00% | $6.0M |
| BGMS | Bio Green Med Solution Inc. | $0.9199 | -7.08% | $6.1M |
| ENVB | Enveric Biosciences Inc. | $1.40 | -4.76% | $6.3M |
| TRAW | Traws Pharma Inc. | $0.4101 | -1.42% | $6.3M |
| FBLG | FibroBiologics Inc. | $0.9599 | -4.01% | $6.5M |
| ALZN | Alzamend Neuro Inc. | $1.35 | +3.05% | $6.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier